---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-256934"
form_type: "8-K"
ticker: "ZYME"
cik: "0001937653"
company_name: "Zymeworks Inc."
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:40:05.725502+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Zymeworks announces director Lota Zoth will not seek re-election; nominates oncology leader Nancy Davidson to board

## Summary
- Director Lota Zoth not standing for re-election at Dec. 7, 2023 annual meeting; will continue as lead independent director until term ends.
- Board nominates Dr. Nancy Davidson for election; if elected, she serves as Class II director with term through 2026 annual meeting.
- Davidson is EVP for Clinical Affairs at Fred Hutchinson Cancer Center, past president of ASCO and AACR, bringing deep oncology expertise.
- If elected, Davidson will receive an initial stock option grant for 50,000 shares under standard non-employee director compensation.
- Company is targeting zanidatamab approval/commercialization and five IND filings before end of 2027.

## SEC filing metadata
- accession: 0001193125-23-256934
- form_type: 8-K
- ticker: ZYME
- cik: 0001937653
- company_name: Zymeworks Inc.
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937653/000119312523256934/0001193125-23-256934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937653/000119312523256934/d569983d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-256934
- JSON: https://secwatch.observer/filing/0001193125-23-256934.json
- Plain text: https://secwatch.observer/filing/0001193125-23-256934.txt

## Key facts
- Executive change
  Lota Zoth departed as Director at Zymeworks Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: Ms. Lota Zoth, a member of the Board of Directors (the “Board”) of Zymeworks Inc. (the “Company”) notified the Company of her decision not to stand for re-election to the Board at the Company’s next annual meeting of stockholders to be held on or about December 7, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1937653/000119312523256934/0001193125-23-256934-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.